Stay updated on GH001 Trial in Treatment-resistant Depression Clinical Trial
Sign up to get notified when there's something new on the GH001 Trial in Treatment-resistant Depression Clinical Trial page.

Latest updates to the GH001 Trial in Treatment-resistant Depression Clinical Trial page
- CheckyesterdayChange DetectedThe site footer revision label changed from v3.8.0 to v3.8.1.SummaryDifference0.1%

- Check8 days agoChange DetectedThe page now presents the ClinicalTrials.gov record for a GH001 trial in people with treatment-resistant depression, including its design, eligibility criteria, locations, and outcome measures, instead of an error page.SummaryDifference49%

- Check15 days agoChange DetectedThe ClinicalTrials.gov page continues to display a 403 Forbidden error. Its footer revision label changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check29 days agoChange DetectedAn NIH-wide notice about changes in terminology appears above the 403 error page, and the site revision identifier advances from v3.7.1 to v3.7.2.SummaryDifference1%

- Check43 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1 on the 403 Forbidden page.SummaryDifference0.2%

- Check50 days agoChange DetectedThe page previously displayed a 403 Forbidden error and related navigation elements, which are now removed, indicating a transition from an error state to normal page content.SummaryDifference0.5%

Stay in the know with updates to GH001 Trial in Treatment-resistant Depression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GH001 Trial in Treatment-resistant Depression Clinical Trial page.